Vesicular drug delivery system - An over view

Research Journal of Pharmaceutical, Biological and Chemical Sciences

Volumn 4, Issue 3, 2013, Pages 462-474

  Buchiraju, Ravi ^a   Nama, Sreekanth ^a   Sakala, Bhargavi ^a   Chandu, Babu Rao ^a   Kommu, Arun ^a   Chebrolu, Jaya Kishore Babu ^a   Yedulapurapu, Narasimhamurthy ^a  

^a Donbosco PG College of Pharmacy   (India)

Author keywords

Drug delivery; Encapsulation; Vesicular system

Indexed keywords

DRUG CARRIER; LIPOSOME; NIOSOME; PHARMACOSOME; SPHINOSOME; TRANSFEROSOME; UFASOME; UNCLASSIFIED DRUG;

ARTICLE; COST BENEFIT ANALYSIS; DRUG COST; DRUG DELIVERY SYSTEM; DRUG ELIMINATION; DRUG HALF LIFE; DRUG METABOLISM; DRUG SOLUBILITY; DRUG STABILITY; DRUG STRUCTURE; DRUG SYNTHESIS; DRUG TARGETING; ENCAPSULATION; HYDROPHILICITY; LIGHT SCATTERING; LIPOPHILICITY; LIPOSOMAL DELIVERY; OSMOTIC PRESSURE; PH; PHYSICAL CHEMISTRY; STRUCTURE ACTIVITY RELATION; SUSTAINED DRUG RELEASE;

EID: 84886396028     PISSN: None     EISSN: 09758585     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. AD Bangha, MM Standish, JG Watkins. J Mol Biol 1965; 13:238.
2. DP Rao, SK Srivastav, C Prasad, R Saxena, S Asthana. Int J Nanotech Application 2010; 1:45-49.
3. S Saraf, R Rathi, CD Kaur, S Saraf. Asian J Scient Res 2011; 4(1):1-15.
4. A Sharma, US Sharma. Int J Pharm 1997; 154:123-140.
5. AD Bangham, RW Horne. J Mol Bio 1964; 8:660-668.
6. DD Lasic. J Colloid Interface Sci 1990; 140:302-304.
7. G Gregoriadis, AT Florence. Drugs Review 1993; 45:15-28.
8. MC Woddle, D Papahadjopoulos. Enzymol 1989:171.
9. G Parthasarthi, N Udupa, GK Pillai. Indian J Pharm Sci 1994; 56 (7):90-94.
10. C Hu,DG Rhodes. Int J Pharm 1999; 185:23-25.
11. RA RajaNaresh, G Chandrashekhar, GK Pillai, N Udupa. Ind J Pharmacol 1994; 2:4648.
12. S Chauhan, MJ Luorence. J Pharm Pharmacol 1989; 41:6.
13. G Buckton; International Phenomenom in Drug Delivery and Targeting, Academic
14. Publishers, Switzerland, 1995.
15. http://www.pharmainfo.net/reviews/niosome-unique-drug-delivery-system.
16. S Verma, SK Singh, N Syan, P Mathur, VJ Valecha. Chem Pharm Res 2010; 2(2):496-509.
17. AA Ismail, A Sanaa, E Gizawy, MA Fouda, MA Donia. AAPS Pharm Sci Tech 2007; 8:4.
18. G Haran, R Coben, LK Bar, Y Barenholz. Biophys Acta 1993; 1151:201.
19. MN Azmin, AT Florence, RM Handjani-Vila, JFB Stuart, G Vanlerberghe, JS Whittaker. J Pharm Pharmacol 1985; 37:237-242.
20. NK Jain. Controlled and novel drug delivery, CBS publishers and distributors, NewDelhi, 2001.
21. Inex Pharmaceutical Corporation Sphingosome for enhanced drug delivery:MS Webb
22. MB Bally, LD Mayor, US Patent 5543152, 1996.
23. SP Vyas, RK Khar. Targeted and controlled drug delivery, CBS publisher and Distributor, New Delhi, 2001.
24. SS Biju, S Talegaonkar, PR Mishra. Indian J Pharm Sci 2006; 68:141-153.
25. M Kanwar. Drug Dev Ind Pharm 2002; 28 (5):473-493.
26. MO Vaizoglu, PP Speiser, Acta Pharm Suec 1986; 23:163-172.
27. A Schatzlein, G Ceve. In; G Cevc, E Paltauf (Ed.), Phospholipid Characterization, Metabolism and novel biological applications, AOCS press, Champaign, 1995,191.
28. Morigaki K, Walde P. Curr Opin Colloid Interface Sci 2007; 12:7580.
29. Gebicki JM, Hicks M. Nature 1973; 243:232-4.
30. Hicks M, Gebicki JM. Chem Phys Lipids 1976; 16:142-60.
31. Barenholz Y. Curr Opin Colloid Interface Sci 2001; 6:66-77.
32. Bittman R, Leventhal AM, Karp S, Blau L, Tremblay PA, Kates M. Chem Phys Lipids 1981; 28:323-35.
33. Lichtenberg D, Freire E, Schmidt CF, Barenholz Y, Felgner PL, Thompson TE. Biochemistry 1981; 20:3462-7.
34. Vanhoogdalem EJ, Deboer AG, Bireimer DD. Pharmacol Ther 1989; 44:407-43.
35. Fukui H, Murakami M, Takada K, Muranishi S. Int J Pharm 1986; 31:239-46.
36. Patel HM, Ryman BE. FEBS Lett 1976; 62:60-3.
37. Patel HM, Stevenson RW, Parsons JA, Ryman BE. Biochem Biophys Acta 1982; 716:18893.
38. Takeuchi H, Yamamoto H, Hino T, Kawashima Y. Pharma Res 1996; 13:896-901.